News
Lumonus inks joint venture with NY cancer centre to scale AI oncology
Lumonus, a GenesisCare spinout chaired by Merrick Howes, is partnering with a New York cancer centre to co-develop automated radiotherapy planning tools.
CPO, Lumonus
Dr Dr. Tim Fox
Roles
| Role | Organisation | Sources |
|---|---|---|
| CPO | Lumonus | Brandon Capital portfolio, Investible |
Coverage
Stories naming Dr Dr. Tim Fox. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
undisclosed
$28m
Investment Notes: Lumonus
Investible announces it backed Lumonus' A$28 million round with three co-investors, the first deal from its new early-stage fund; Lumonus builds AI software that automates cancer clinic workflows.